Abstract
OBJECTIVE: In cardiovascular regulation, heme oxygenase-1 (HO-1) activity has been shown to inhibit vascular smooth muscle cell (VSMC) proliferation by promoting cell cycle arrest at the G1/S phase. However, the effect of HO-1 on VSMC migration remains unclear. We aim to elucidate the mechanism by which HO-1 regulates PDGFBB-induced VSMC migration.
METHODS AND RESULTS: Transduction of HO-1 cDNA adenoviral vector severely impeded human VSMC migration in a scratch, transmembrane, and directional migration assay in response to PDGFBB stimulation. Similarly, HO-1 overexpression in the remodeling process during murine retinal vasculature development attenuated VSMC coverage over the major arterial branches as compared with sham vector-transduced eyes. HO-1 expression in VSMCs significantly upregulated VEGFA and VEGFR2 expression, which subsequently promoted the formation of inactive PDGFRβ/VEGFR2 complexes. This compromised PDGFRβ phosphorylation and impeded the downstream cascade of FAK-p38 signaling. siRNA-mediated silencing of VEGFA or VEGFR2 could reverse the inhibitory effect of HO-1 on VSMC migration.
CONCLUSIONS: These findings identify a potent antimigratory function of HO-1 in VSMCs, a mechanism that involves VEGFA and VEGFR2 upregulation, followed by assembly of inactive VEGFR2/PDGFRβ complexes that attenuates effective PDGFRβ signaling.
Original language | English |
---|---|
Pages (from-to) | 1289-98 |
Number of pages | 10 |
Journal | Arteriosclerosis, Thrombosis and Vascular Biology |
Volume | 32 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- Cell Movement
- Cell Proliferation
- Heme Oxygenase-1
- Humans
- Muscle, Smooth, Vascular
- Platelet-Derived Growth Factor
- RNA, Messenger
- Receptor, Platelet-Derived Growth Factor beta
- Signal Transduction
- Up-Regulation
- Vascular Endothelial Growth Factor Receptor-2